quadraScope will be speaking at Life Science Nation’s Redefining Early Stage Investments conference QUADSMaster March 16, 2024
Solving DNA mutations central to aging and disease – interview with Chris Bradley QUADSMaster December 9, 2023
quadraScope presented two posters at the 2023 Biomarkers of Aging Symposium QUADSMaster December 6, 2023
Turn Bio receives positive feedback following an FDA INTERACT meeting to advance epigenetic reprogramming for skin rejuvenation into clinical trials QUADSMaster October 25, 2023